BellRing Brands Share Holder Equity 2019-2024 | BRBR

BellRing Brands share holder equity from 2019 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • BellRing Brands share holder equity for the quarter ending September 30, 2024 was $-0.206B, a 36.35% decline year-over-year.
  • BellRing Brands share holder equity for 2024 was $-0.206B, a 36.35% decline from 2023.
  • BellRing Brands share holder equity for 2023 was $-0.324B, a 14.01% decline from 2022.
  • BellRing Brands share holder equity for 2022 was $-0.376B, a 87.72% decline from 2021.
BellRing Brands Annual Share Holder Equity
(Millions of US $)
2024 $-206
2023 $-324
2022 $-376
2021 $-3,063
2020 $-2,183
2019 $486
2018 $0
BellRing Brands Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $-206
2024-06-30 $-243
2024-03-31 $-248
2023-12-31 $-287
2023-09-30 $-324
2023-06-30 $-365
2023-03-31 $-363
2022-12-31 $-370
2022-09-30 $-376
2022-06-30 $-390
2022-03-31 $-429
2021-12-31 $-2,828
2021-09-30 $-3,063
2021-06-30 $-3,155
2021-03-31 $-2,435
2020-12-31 $-2,500
2020-09-30 $-2,183
2020-06-30 $-2,137
2020-03-31 $-1,863
2019-12-31 $-2,278
2019-09-30 $486
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.817B $1.996B
BellRing Brands, Inc. manufactures and sells nutrition products. The company offers protein shakes, other RTD beverages, powders and nutrition bars and supplements. It offers products under the Premier Protein, Dymatize and PowerBar, as well as Joint Juice and Supreme Protein brands. BellRing Brands, Inc. is based in St. Louis, Missouri.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.284B 25.22
Stryker (SYK) United States $148.861B 33.55
Boston Scientific (BSX) United States $147.840B 42.50
EssilorLuxottica (ESLOY) France $120.398B 0.00
Medtronic (MDT) Ireland $112.636B 16.73
Lonza Group Ag (LZAGY) Switzerland $46.153B 0.00
Haleon (HLN) United Kingdom $41.736B 27.12
GE HealthCare Technologies (GEHC) United States $39.899B 20.69
ResMed (RMD) United States $36.307B 29.83
Terumo (TRUMY) Japan $28.860B 40.76
Koninklijke Philips (PHG) Netherlands $24.692B 18.90
Zimmer Biomet Holdings (ZBH) United States $21.842B 13.91
Insulet (PODD) United States $19.563B 77.90
Baxter (BAX) United States $16.252B 10.57
Smith & Nephew SNATS (SNN) United Kingdom $11.030B 0.00
Bio-Rad Laboratories (BIO) United States $10.094B 34.30
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.632B 15.41
ICU Medical (ICUI) United States $4.089B 38.93
Prestige Consumer Healthcare (PBH) United States $3.823B 19.01
Haemonetics (HAE) United States $3.684B 17.98
Envista Holdings (NVST) United States $3.623B 26.99
Perrigo (PRGO) Ireland $3.281B 9.66
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.992B 19.25
GN Store Nord (GNNDY) Denmark $2.797B 17.94
Neogen (NEOG) United States $2.592B 29.88
LeMaitre Vascular (LMAT) United States $2.203B 53.55
AtriCure (ATRC) United States $1.926B 0.00
Green Thumb Industries (GTBIF) United States $1.514B 26.50
InMode (INMD) Israel $1.434B 8.62
AdaptHealth (AHCO) United States $1.368B 9.78
Maravai LifeSciences Holdings (MRVI) United States $1.343B 0.00
BioLife Solutions (BLFS) United States $1.274B 0.00
Owens & Minor (OMI) United States $1.145B 8.95
Curaleaf Holdings (CURLF) Canada $0.903B 0.00
Evolus (EOLS) United States $0.895B 0.00
Phibro Animal Health (PAHC) United States $0.881B 15.54
CeriBell (CBLL) United States $0.833B 0.00
Capricor Therapeutics (CAPR) United States $0.678B 0.00
VAREX IMAGING (VREX) United States $0.572B 25.24
Omeros (OMER) United States $0.538B 0.00
Surmodics (SRDX) United States $0.530B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.418B 0.00
ZimVie (ZIMV) United States $0.391B 32.91
Quanterix (QTRX) United States $0.386B 0.00
Valneva SE (VALN) France $0.376B 0.00
Cerus (CERS) United States $0.336B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Biote (BTMD) United States $0.307B 6.73
OraSure Technologies (OSUR) United States $0.290B 19.45
Canopy Growth (CGC) Canada $0.263B 0.00
Zynex (ZYXI) United States $0.261B 54.53
High Tide (HITI) Canada $0.244B 100.33
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.213B 14.71
Aurora Cannabis (ACB) Canada $0.212B 0.00
Brainsway (BWAY) Israel $0.208B 110.50
Organigram Holdings (OGI) Canada $0.198B 0.00
MacroGenics (MGNX) United States $0.193B 0.00
TerrAscend (TSNDF) Canada $0.153B 0.00
Veru (VERU) United States $0.152B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.29
Jin Medical (ZJYL) China $0.136B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.097B 11.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
InterCure (INCR) Israel $0.078B 0.00
INLIF (INLF) $0.074B 0.00
Exagen (XGN) United States $0.071B 0.00
Rockwell Medical (RMTI) United States $0.070B 36.33
Apyx Medical (APYX) United States $0.057B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Safety Shot (SHOT) United States $0.029B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
United-Guardian (UG) United States $0.000B 14.07
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00